Fortress Biotech, Inc. (FBIO) Stock Overview
Explore Fortress Biotech, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Fortress Biotech, Inc. (FBIO)
Key Financials
Key Financials
Market Cap
68.8M
P/E Ratio
0.64
EPS (TTM)
$2.64
ROE
1.04%
FBIO Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Fortress Biotech, Inc. (NASDAQ: FBIO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Fortress Biotech, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of FBIO on the NASDAQ shows an RSI of 23.23, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $3.49 for the NASDAQ listing.
Key metrics behind Fortress Biotech, Inc.'s NASDAQ-traded stock include a P/E ratio of 0.64 and a market capitalization of 68.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of FBIO on the NASDAQ.